{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:00:49Z","timestamp":1794013249510,"version":"4.8.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T00:00:00Z","timestamp":1405900800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-523","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T07:01:12Z","timestamp":1405926072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study"],"prefix":"10.1186","volume":"14","author":[{"given":"Jan","family":"Schovanek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Martucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Fojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydira","family":"del Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Frysak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,21]]},"reference":[{"key":"4705_CR1","volume-title":"Pathology and genetics of tumours of endocrine organs","author":"RA DeLellis","year":"2004","unstructured":"DeLellis RA: Pathology and genetics of tumours of endocrine organs. 2004, Lyon: IARC Press"},{"issue":"11","key":"4705_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","volume":"287","author":"JW Lenders","year":"2002","unstructured":"Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G: Biochemical diagnosis of pheochromocytoma: which test is best?. JAMA. 2002, 287 (11): 1427-1434.","journal-title":"JAMA"},{"issue":"1","key":"4705_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti D, Latif F, Dallol A, Dahia PLM, Douglas F, George E, Sk\u221a\u2202ldberg F, Husebye ES, Eng C, Maher ER: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial Pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001, 69 (1): 49-54.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"4705_CR4","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1210\/jc.2006-0423","volume":"91","author":"FM Brouwers","year":"2006","unstructured":"Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K: High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab. 2006, 91 (11): 4505-4509.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4705_CR5","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","volume":"92","author":"L Amar","year":"2007","unstructured":"Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP, Plouin PF: Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab. 2007, 92 (10): 3822-3828.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4705_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG: Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab. 2006, 91 (3): 827-836.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4705_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/jhh.2012.20","volume":"27","author":"D Karasek","year":"2013","unstructured":"Karasek D, Shah U, Frysak Z, Stratakis C, Pacak K: An update on the genetics of pheochromocytoma. J Hum Hypertens. 2013, 27 (3): 141-147.","journal-title":"J Hum Hypertens"},{"issue":"8","key":"4705_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004, 292 (8): 943-951.","journal-title":"JAMA"},{"issue":"34","key":"4705_CR9","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP: Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol. 2005, 23 (34): 8812-8818.","journal-title":"J Clin Oncol"},{"key":"4705_CR10","volume-title":"Conn\u2019s Current Therapy 2013: Expert Consult: Online","author":"ET Bope","year":"2012","unstructured":"Bope ET, Kellerman RD: Conn\u2019s Current Therapy 2013: Expert Consult: Online. 2012, Philadelphia, Pa: Elsevier Health Sciences"},{"issue":"7","key":"4705_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s002689900139","volume":"20","author":"DS O\u2019Riordain","year":"1996","unstructured":"O\u2019Riordain DS, Young WF, Grant CS, Carney JA, van Heerden JA: Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg. 1996, 20 (7): 916-921. discussion 922","journal-title":"World J Surg"},{"issue":"11","key":"4705_CR12","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","volume":"48","author":"G Eisenhofer","year":"2012","unstructured":"Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K: Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012, 48 (11): 1739-1749.","journal-title":"Eur J Cancer"},{"issue":"20","key":"4705_CR13","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","volume":"20","author":"N Burnichon","year":"2011","unstructured":"Burnichon N, Vescovo L, Amar L, Libe R, de Reynies A, Venisse A, Jouanno E, Laurendeau I, Parfait B, Bertherat J, Plouin PF, Jeunemaitre X, Favier J, Gimenez-Roqueplo AP: Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet. 2011, 20 (20): 3974-3985.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"4705_CR14","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1210\/me.2010-0256","volume":"24","author":"E Lopez-Jimenez","year":"2010","unstructured":"Lopez-Jimenez E, Gomez-Lopez G, Leandro-Garcia LJ, Munoz I, Schiavi F, Montero-Conde C, de Cubas AA, Ramires R, Landa I, Leskela S, Maliszewska A, Inglada-Perez L, de la Vega L, Rodriguez-Antona C, Leton R, Bernal C, de Campos JM, Diez-Tascon C, Fraga MF, Boullosa C, Pisano DG, Opocher G, Robledo M, Cascon A: Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. Mol Endocrin (Baltimore, Md). 2010, 24 (12): 2382-2391.","journal-title":"Mol Endocrin (Baltimore, Md)"},{"issue":"1","key":"4705_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12022-011-9188-1","volume":"23","author":"G Eisenhofer","year":"2012","unstructured":"Eisenhofer G, Tischler AS, de Krijger RR: Diagnostic tests and biomarkers for Pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr Pathol. 2012, 23 (1): 4-14.","journal-title":"Endocr Pathol"},{"issue":"6","key":"4705_CR16","doi-asserted-by":"publisher","first-page":"E954","DOI":"10.1210\/jc.2011-3437","volume":"97","author":"C Loriot","year":"2012","unstructured":"Loriot C, Burnichon N, Gadessaud N, Vescovo L, Amar L, Libe R, Bertherat J, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP, Favier J: Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations. J Clin Endocrinol Metab. 2012, 97 (6): E954-962.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4705_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1365-2362.2011.02518.x","volume":"41","author":"T Zelinka","year":"2011","unstructured":"Zelinka T, Musil Z, Duskova J, Burton D, Merino MJ, Milosevic D, Widimsky J, Pacak K: Metastatic pheochromocytoma: does the size and age matter?. Eur J Clin Invest. 2011, 41 (10): 1121-1128.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"4705_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","volume":"57","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K: Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem. 2011, 57 (3): 411-420.","journal-title":"Clin Chem"},{"issue":"3","key":"4705_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C: Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011, 96 (3): 717-725.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4705_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ncpendmet0396","volume":"3","author":"K Pacak","year":"2007","unstructured":"Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS: Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab. 2007, 3 (2): 92-102.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"4705_CR21","volume-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"2010","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C, International Union against C: TNM classification of malignant tumours. 2010, Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell"},{"issue":"1","key":"4705_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/humu.21136","volume":"31","author":"CJ Ricketts","year":"2010","unstructured":"Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER: Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat. 2010, 31 (1): 41-51.","journal-title":"Hum Mutat"},{"issue":"31","key":"4705_CR23","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","volume":"29","author":"KS King","year":"2011","unstructured":"King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M, Wesley R, Lodish M, Raygada M, Gimenez-Roqueplo AP, McCormack S, Eisenhofer G, Milosevic D, Kebebew E, Stratakis CA, Pacak K: Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol. 2011, 29 (31): 4137-4142.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4705_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/jso.23297","volume":"107","author":"P Goffredo","year":"2013","unstructured":"Goffredo P, Sosa JA, Roman SA: Malignant Pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades. J Surg Oncol. 2013, 107 (6): 659-664.","journal-title":"J Surg Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-523\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:15:32Z","timestamp":1630545332000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,21]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4705"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-523","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,21]]},"assertion":[{"value":"23 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"523"}}